World News: 16:46 GMT Thursday 6th December 2018. [Valneva via Globe Newswire via SPi World News]
Under the terms of the agreement Valneva Sweden will provide analytical services develop process scale-up and produce GMP clinical trial material to support the development of new immunotherapies based on HOOKIPAs Vaxwaveand TheraTarenavirus vect or- tec...
Globe Newswire: 16:46 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.